PVI
BSX icon

Pura Vida Investments’s Boston Scientific BSX Stock Holding History

Pura Vida Investments’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-230,000
Closed -$5.7M – 71
2017
Q4 		$5.7M Buy
+230,000
New +$6.34M 2.39% 14

Other funds holding BSX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Pura Vida Investments's BSX Position: Q4 2022 in Review

Pura Vida Investments sold out of Boston Scientific (BSX) in Q4 2022, closing a stake of 48,635 shares — an estimated $1.88M sold.

Pura Vida Investments first reported a position in BSX in Q4 2014 and held it in 22 quarters. The position peaked at $11.7M in Q2 2017. 929 funds tracked by Wall St. Rank hold BSX as of Q4 2022.

  • Pura Vida Investments reported no remaining Boston Scientific position as of Q4 2022 after selling out during the quarter.
  • Pura Vida Investments sold 48,635 Boston Scientific shares in Q4 2022, an estimated $1.88M.
  • Pura Vida Investments first reported a position in Boston Scientific in Q4 2014 and held it in 22 quarters.
  • Pura Vida Investments's Boston Scientific position peaked at $11.7M in Q2 2017.
  • 929 funds tracked by Wall St. Rank held Boston Scientific as of Q4 2022.

Based on Pura Vida Investments's 13F filing for Q4 2022, filed 14 Feb 2023.